Eli Shani - 10 Aug 2022 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
EVP,Global Marketing&Portfolio
Signature
/s/ Dov Bergwerk as attorney-in-fact for Eli Shani
Issuer symbol
TEVA
Transactions as of
10 Aug 2022
Net transactions value
$0
Form type
4
Filing time
11 Aug 2022, 07:05:25 UTC
Previous filing
08 Mar 2022
Next filing
02 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +1,581 +8.7% 19,741 10 Aug 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Options Exercise $0 -1,581 -100% $0.000000* 0 10 Aug 2022 Ordinary Shares 1,581 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 Restricted share units were granted on August 10, 2018, with 1,581 vesting on August 10, 2022.